Showing results (501-510 of 515) with videos related to

Sort By:
Pageof 52
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2025
Cas9-mediated gene-editing frequency in microalgae is doubled by harnessing the interaction between importin α and phytopathogenic NLSsTrang Thi Le, Hong Il Choi, Ji Won Kim, et al.
European Journal of Medicinal Chemistry|August 14, 2018
Identification of crizotinib derivatives as potent SHIP2 inhibitors for the treatment of Alzheimer's diseaseJi Woong Lim, Seok Kyu Kim, Seo Yun Choi, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 19, 2022
Battery-Free, Wireless, Ionic Liquid Sensor Arrays to Monitor Pressure and Temperature of Patients in Bed and WheelchairHyeonseok Han, Yong Suk Oh, Seokjoo Cho, et al.
Molecular Metabolism|June 24, 2025
Housing matters: Experimental variables shaping metabolism in obese miceBéatrice So-Yun Choi, Jacob Bak Holm, Asker Brejnrod, et al.
Chemical Engineering Journal (Lausanne, Switzerland : 1996)|March 22, 2022
Photobiocidal-triboelectric nanolayer coating of photosensitizer/silica-alumina for reusable and visible-light-driven antibacterial/antiviral air filtersSang Bin Jeong, Dong Uk Lee, Byeong Jin Lee, et al.
Leukemia & Lymphoma|April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failureEmily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
Stem Cells and Development|March 21, 2013
Isolation and characterization of novel, highly proliferative human CD34/CD73-double-positive testis-derived stem cells for cell therapyWon Yun Choi, Hwang Gyun Jeon, Young Chung, et al.
American Journal of Hematology|January 11, 2023
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphomaSanjal H Desai, Michael A Spinner, Kevin David, et al.
Blood Cancer Journal|June 24, 2026
Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphomaSanjal H Desai, Susan M Geyer, Levi Pederson, et al.
Blood Advances|September 20, 2023
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent eraSanjal H Desai, Michael A Spinner, Andrew M Evens, et al.
Pageof 52